Lixte Biotechnology Holdings, Inc. (LIXT) earnings
LIXT earnings moved a median of -1.09% by the close. Quarterly and annual LIXT reports and results, each read against the price at its own news timestamp. Back to the LIXT overview →
14 measured LIXT earnings events.
Where these LIXT earnings landedvs 12 measured LIXT earnings reactions
| Middle 50% of LIXT earnings reactions | -2.54% to +0.63% |
|---|---|
| Median reaction (to close) | -1.09% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 LIXT earnings events with a measured close landed between -2.54% and +0.63%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NOMAD POWER SOLUTIONS, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Mar 31 | SEC filing · Form 10-Q | +2.94% | -5.15% | |
| LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update | Press release | +2.94% | -5.15% | |
| Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31 | SEC filing · Form 10-K | +1.97% | +0.99% | |
| LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year | Press release | +1.45% | -1.45% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Sep 30 | SEC filing · Form 10-Q | +1.48% | — | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Jun 30 | SEC filing · Form 10-Q | +1.56% | +8.82% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Mar 31 | SEC filing · Form 10-Q | — | -1.54% | |
| Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31 | SEC filing · Form 10-K | — | +6.35% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -0.61% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.51% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Mar 31 | SEC filing · Form 10-Q | — | -0.73% | |
| Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31 | SEC filing · Form 10-K | — | -3.77% | |
| Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Sep 30 | SEC filing · Form 10-Q | +1.03% | -2.13% |
Keep exploring
More LIXT: analyst actions → · SEC filings → · LIXT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Resverlogix Corp (RVX_TSE) | 240 | 0.00% | 32% |
| Artelo Biosciences, Inc. (ARTL) | 239 | 0.00% | 41% |
| MeiraGTx Holdings plc - Ordinary Shares (MGTX) | 239 | -0.10% | 46% |
| Ovid Therapeutics Inc. (OVID) | 239 | -0.32% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.